Publications Chair & Editor-in-Chief:
Nicholas Athanasiou, MD, MBA, DFASAM
Co-Editors:
Brandon Aden, MD
John A. Fromson, MD
Jack Woodside, MD
ASAM Staff Producer:
Zach Caruso
This Week in Addiction Medicine is an audio summary of the recent top stories and research articles from the field of addiction medicine. Intended to serve as an accompaniment to the ASAM Weekly newsletter or as a stand-alone resource, This Week covers recent publications in addiction medicine research.
This Week in Addiction Medicine is an audio summary of the recent top stories and research articles from the field of addiction medicine. Intended to serve as an accompaniment to the ASAM Weekly newsletter or as a stand-alone resource, This Week covers recent publications in addiction medicine research.
Tuesday May 23, 2023
Tuesday May 23, 2023
Tuesday May 23, 2023
Lead Story
Racial Inequality in Receipt of Medications for Opioid Use Disorder
The New England Journal of Medicine
Opioid overdose mortality has increased over the last ten years, but disproportionately among Black persons. The authors examine racial disparities in receipt of buprenorphine and naloxone after opioid use disorder (OUD) related events using Medicare data from 2016-2019. They found that Black persons were less likely to receive buprenorphine (12.7 vs 23.3%) and naloxone (14.4% vs 22.9%) than White persons within six months after the event. Further, Black persons received lower day supply of buprenorphine and were less likely to be retained on treatment. Of note, Black and White persons had similar rates of ambulatory visits in the 6 months after the event, indicating patient and provider-level barriers to access.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Tuesday May 16, 2023
Tuesday May 16, 2023
Tuesday May 16, 2023
Lead Story:
Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal
The New England Journal of Medicine
This multicenter randomized controlled trial was undertaken to evaluate the the Eat, Sleep, Console Care Tool vs usual care for neonatal opioid withdrawal with the primary outcome being medically ready for hospital discharge. The Eat, Sleep, Console Care Tool relies on an assessment of withdrawal severity focused on an infant’s ability to eat, sleep, and be consoled, along with the use of nonpharmacologic interventions as first line of treatment. The Eat, Sleep, Console care approach decreased the time until infants with opioid withdrawal were medically ready for discharge by a mean of 6.7 days, and the proportion of infants receiving pharmacologic treatment by 32.5%. Hence, this approach facilitates more judicious use of medication for these infants.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Friday May 12, 2023
Friday May 12, 2023
Friday May 12, 2023
Article Referenced:
Noel, Marnie PharmD, BCPP; et all. The Howard Street Method: A Community Pharmacy-Led Low Dose Overlap Buprenorphine Initiation Protocol for Individuals Using Fentanyl. Journal of Addiction Medicine.
ASAM Resources:
2020 National Practice Guideline for the Treatment of Opioid Use Disorder
OUD Treatment Education
Sign Up for the Q&S Newsletter
Sign Up for the ASAM Weekly
ASAM Membership
Tuesday May 09, 2023
Tuesday May 09, 2023
Lead Story
Subtypes in addiction and their neurobehavioral profiles across three functional domains
Translational Psychiatry
Over two-thirds of the 40.3 million people in the U.S. who have a substance use disorder (SUD) return to use within weeks to months of initiating treatment, and up to 85% of individuals return to substance use within one year of treatment completion. This study hypothesized that considerable individual differences exist in the three functional domains underlying addiction — approach-related behavior, executive function, and negative emotionality. Results support functionally derived subtypes, demonstrating considerable individual heterogeneity in the multi-dimensional impairments in addiction. This confirms the need for mechanism-based subtyping to inform the development of personalized addiction medicine approaches.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Tuesday May 02, 2023
Tuesday May 02, 2023
Lead Story:
The conserved endocannabinoid anandamide modulates olfactory sensitivity to induce hedonic feeding in C. elegans
Current Biology
Laboratory worm Caenorhabditis elegans apparently gets the ‘munchies’ when exposed to cannabis. After soaking in an endocannabinoid bath, worms preferred to eat nutrient-rich, rather than nutrient-poor, bacteria. They fed for longer than worms not exposed to endocannabinoid or worms without working endocannabinoid receptors. This shared trait points to the deep evolutionary origin of cannabinoid receptors and behaviors influenced by the molecules.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Tuesday Apr 25, 2023
Tuesday Apr 25, 2023
Tuesday Apr 25, 2023
Lead Story:
Opioid Prescribing and Suicide Risk in the United States
The American Journal of Psychiatry
Approximately 40% of overdose suicide deaths in the United States involve opioids. Because of their respiratory depression effects and narrow therapeutic window, opioids pose a greater risk than any other drug class of an intentional overdose proving to be lethal. In this retrospective study of US commuting zone–level opioid prescriptions and mortality, regional decreases in opioid prescriptions were consistently associated with declines in total suicide deaths, including suicide overdose deaths involving opioids. For some opioid prescribing measures, negative associations were observed with unintentional overdose deaths involving opioids among younger people. Individual-level inferences are limited by the ecological nature of the analysis.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Tuesday Apr 18, 2023
Tuesday Apr 18, 2023
Tuesday Apr 18, 2023
Lead Story
Association Between Daily Alcohol Intake and Risk of All-Cause Mortality
JAMA Network Open
This updated systematic review and meta-analysis investigated the association between alcohol use and all-cause mortality. Among occasional (>0 to
Tuesday Apr 11, 2023
Tuesday Apr 11, 2023
Lead Story:
Shared genetic liability for alcohol consumption, alcohol problems, and suicide attempt: Evaluating the role of impulsivity
Translational Psychiatry
This study investigated the extent to which shared liability for alcohol consumption and problems (ACP) and suicide attempt (SA) is genetically related to five dimensions of impulsivity. Common genetic liability to ACP and SA was significantly correlated with all five impulsive personality traits examined, and the largest correlation was with lack of premeditation, though supplementary analyses suggested that these findings were potentially more strongly influenced by ACP than SA. These analyses have potential implications for screening and prevention: Impulsivity can be comprehensively assessed in childhood, whereas heavy drinking and suicide attempt are quite rare prior to adolescence. Features of impulsivity may serve as early indicators of genetic risk for alcohol problems and suicidality.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Tuesday Apr 04, 2023
Tuesday Apr 04, 2023
Lead Story:
Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders
Nature Mental Health
Recent large-scale genome-wide association studies (GWASs) show that the genetic architecture of substance use disorders (SUDs) is characterized by a high degree of commonality, i.e., a general addiction genetic factor likely conveys vulnerability to multiple SUDs. Genetic liability to substance use disorders can be parsed into loci that confer general or substance-specific addiction risk. This is a multivariate genome-wide association meta-analysis that disaggregates general and substance-specific loci from published summary statistics of SUDs. Findings provide insight into genetic risk loci for substance use disorders that could be leveraged as treatment targets.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Thursday Mar 30, 2023
Thursday Mar 30, 2023
Thursday Mar 30, 2023
Special Guest:
Lewis S. Nelson, MD, MBA, DFASAM
Article Referenced:
R.J. Strayer et al., EMERGENCY DEPARTMENT MANAGEMENT OF PATIENTS WITH ALCOHOL INTOXICATION, ALCOHOL WITHDRAWAL, AND ALCOHOL USE DISORDER: A WHITE PAPER PREPARED FOR THE AMERICAN ACADEMY OF EMERGENCY MEDICINE, Journal of Emergency Medicine, https://doi.org/10.1016/j.jemermed.2023.01.010
ASAM Resources:
The ASAM Clinical Practical Guideline on Alcohol Withdrawal Management
Alcohol Withdrawal Management Pocket Guide
Sign Up for the Q&S Newsletter
Sign Up for the ASAM Weekly
ASAM Membership

ASAM, founded in 1954, is a professional medical society representing over 7,000 physicians, clinicians, and associated professionals in the field of addiction medicine.
ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.
Visit www.ASAM.org for more information.
Publications Chair & Editor-in-Chief:
Nicholas Athanasiou, MD, MBA, DFASAM
Co-Editors:
Brandon Aden, MD
John A. Fromson, MD
Jack Woodside, MD
ASAM Staff Producer:
Zach Caruso
Disclaimer:
This podcast is for informational purposes only and should not be considered health advice.
• We are not responsible for any losses, damages, or liabilities that may arise from the use of this podcast.
• This podcast is not intended to replace professional medical advice.
• The views expressed in this podcast may not be those of the host or the management.